Company intelligence / Profile preview

C-RAD

Uppsala, Sweden
Ownership
Private
Development stage
Other
01

Overview

C-RAD's Surface Guided Radiation Therapy solutions (notably the Catalyst™ system) are broadly adopted for clinical use in radiation oncology worldwide, delivering improved patient positioning, motion management, and workflow efficiency in commercial settings[1][2][3].

Therapeutic areas
Oncology
Modalities
Device
Industry
Therapeutic Medical Devices
02

Partnerships

ElektaAccuray

Beyond the preview

Go deeper on C-RAD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-RAD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call